American Journal of Kidney Diseases
Volume 51, Issue 2 , Pages 165-168 , February 2008

Prophylaxis Against Dialysis Catheter–Related Bacteremia: A Glimmer of Hope

  • Michael Allon, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Michael Allon, MD, Division of Nephrology, University of Alabama at Birmingham, PB, Room 226, 728 Richard Arrington Blvd, Birmingham, AL 35294.

References 

  1. Allon M. Dialysis catheter-related bacteremia: Treatment and prophylaxis. Am J Kidney Dis. 2004;44:779–791
  2. Lee T, Barker J, Allon M. Tunneled catheters in hemodialysis patients: Reasons and subsequent outcomes. Am J Kidney Dis. 2005;46:501–508
  3. Centers for Medicare and Medicaid Services. 2004 annual report: End-stage renal disease clinical performance measures project. Am J Kidney Dis. 2005;46:1–100
  4. Donlan RM. Biofilm formation: a clinically relevant microbiologic process. Clin Infect Dis. 2001;33:1387–1392
  5. Shah CB, Mittelman MW, Costerton JW, et al. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother. 2002;46:1674–1679
  6. Weijmer MC, Debets-Ossenkopp YJ, van der Vondervoort FJ, et al. Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant. 2002;17:2189–2195
  7. Jaffer Y, Selby NM, Taal MW, et al. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis. 2008;51:233–241
  8. Dogra GK, Herson H, Hutchison B, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol. 2002;13:2133–2139
  9. Kim SH, Song KI, Chang JW, et al. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: A prospective randomized clinical trial. Kidney Int. 2006;69:161–164
  10. McIntyre CW, Hulme LJ, Taal M, et al. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int. 2004;66:801–805
  11. Nori US, Manoharan A, Yee J, et al. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis. 2006;48:596–605
  12. Saxena AK, Panhotra BR, Sundaram DS, et al. Enhancing the survival of tunneled hemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial. Nephrology (Carlton). 2006;11:299–305
  13. Betjes MGH, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant. 2004;19:1546–1551
  14. Weijmer MC, Van den Dorpel A, Van de Ven PJG, et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol. 2005;16:2769–2777
  15. Guerraoui AA, Dacosta EE, Roche BB, et al. Emergence of multiresistant Staphylococcus epidermidis (MRSE) after lock antibiotic regimen by gentamicin in permanent hemodialysis catheters (Prospective study, 1999-2003). J Am Soc Nephrol. 2004;15:368A;(abstr)
  16. Food and Drug Administration. FDA Talk Paper: FDA Issues Warning on Tricitrasol Dialysis Catheter Anticoagulant. http://www.fda.gov/bbs/topics/answers/ANS01009.htmlAccessed November 21, 2007
  17. Reaven NL. Cost of hemodialysis catheter-related complications. J Am Soc Nephrol. 2003;14:243A;(abstr)

PII: S0272-6386(07)01602-2

doi: 10.1053/j.ajkd.2007.12.003

American Journal of Kidney Diseases
Volume 51, Issue 2 , Pages 165-168 , February 2008

Article Tools

* Image Usage & Resolution